Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 7.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments

Jeffrey T. Leek, W. Evan Johnson, Hilary S. Parker et al. · Bioinformatics · 2012 · 6.7K citations · Full text

Life Sciences, Bioinformatics, Biostatistics +7

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo, Richard S. Finn, Shukui Qin et al. · The Lancet · 2018 · 5.4K citations · Full text

Medicine, Oncology, Pharmacology +12

Determining cell type abundance and expression from bulk tissues with digital cytometry

Aaron M. Newman, Chloé B. Steen, Chih Long Liu et al. · Nature Biotechnology · 2019 · 4.9K citations

Life Sciences, Cell Biology, Molecular Biology +16